Among them, HDAC1 and HDAC2 are class I HDACs, whose increased expression is an independent risk factor for poor prognosis of malignant ovarian tumors (Khabele et al., 2007; Weichert et al., 2008). The gene discussed is HDAC2; the disease is ovarian cancer.